Related Experiment Video

Updated: Apr 21, 2026

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

2.7K

[Molecular mechanism of Doxorubicin resistance in multiple myeloma cell line]

Yan-Yan Lu1, Cui-Rong Xiao1, Hua-Ying Chen1

  • 1Department of Hematology, Xiamen University Zhongshan Hospital, Xiamen 361004,Fujian Province, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi
|October 24, 2014
PubMed

Insights

This study reveals Notch signaling activation correlates with doxorubicin resistance in multiple myeloma cells. Targeting Notch signaling may offer a new therapeutic strategy for overcoming drug resistance in myeloma.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pharmacology

Context:

  • Multiple myeloma is a hematological malignancy characterized by uncontrolled proliferation of plasma cells.
  • Acquired resistance to chemotherapeutic agents like doxorubicin poses a significant challenge in multiple myeloma treatment.
  • Understanding the molecular mechanisms underlying drug resistance is crucial for developing effective therapeutic strategies.

Purpose:

  • To investigate the molecular mechanisms of doxorubicin resistance in a multiple myeloma cell line.
  • To evaluate the impact of Notch signaling pathway activation on drug resistance in multiple myeloma.
  • To establish a doxorubicin-resistant multiple myeloma cell line for further mechanistic studies.

Summary:

  • A doxorubicin-resistant RPMI 8226 cell line (RPMI8226/DOX) was established and characterized.
  • Increased mRNA expression of Notch2, Jagged1, and Jagged2, along with elevated P-170 protein and higher levels of VEGF and IL-6, were observed in resistant cells.
  • Conversely, HES1 mRNA expression decreased with increasing drug resistance.

Impact:

  • The RPMI8226/DOX cell line serves as a valuable model for studying chemotherapeutic drug resistance in multiple myeloma.
  • Notch pathway activation is identified as a key factor associated with drug resistance in multiple myeloma.
  • The findings suggest that Notch signaling could be a potential therapeutic target for overcoming doxorubicin resistance in multiple myeloma.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

12.8K
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

7.7K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
6.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K